List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 5 studies with search of:   "Oncotherapeutics" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Drug: dexamethasone;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: immunologic technique;   Procedure: protein analysis
2 Active, not recruiting Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: ascorbic acid;   Drug: bortezomib;   Drug: melphalan
3 Active, not recruiting Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Drug: samarium Sm 153 lexidronam pentasodium
4 Withdrawn Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Stage II Multiple Myeloma;   Stage III Multiple Myeloma;   Refractory Plasma Cell Neoplasm
Interventions: Drug: arsenic trioxide;   Drug: ascorbic acid;   Drug: melphalan;   Procedure: chemosensitization/potentiation;   Procedure: chemotherapy
5 Not yet recruiting Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: melphalan;   Drug: panobinostat

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options